David Matthew T
SEC insider (Form 3/4/5 filer). CIK 0001811612. Chief Financial Officer at Actinium Pharmaceuticals, Inc. (ATNM) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Oct 14, 2026. Located in NEW YORK, NY.
Companies David Matthew T has filed insider reports for
- Actinium Pharmaceuticals, Inc. (ATNM): Officer, Chief Financial Officer
- CorMedix Inc. (CRMD): Officer, Chief Financial Officer
David Matthew T
CIK: 0001811612
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Oct 14, 2026ATNM
Actinium Pharmaceuticals, Inc.
AwardDirect250K shares- - Jan 10, 2025CRMD
CorMedix Inc.
Tax PaymentDirect6.5K shares at avg. $11.19$73K - Jan 2, 2025CRMD
CorMedix Inc.
AwardDirect62.5K shares- - Jan 2, 2025CRMD
CorMedix Inc.
Tax PaymentDirect8.6K shares at avg. $8.22$71K
1-4 of 4 transactions